pd 98059 has been researched along with anandamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Petrocellis, L; Di Marzo, V; Galve-Roperh, I; Guzmán, M; Melck, D; Rueda, D | 1 |
Milton, NG | 1 |
2 other study(ies) available for pd 98059 and anandamide
Article | Year |
---|---|
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells.
Topics: Arachidonic Acids; Breast Neoplasms; Cell Division; Cell Line; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Endocannabinoids; Flavonoids; Humans; Mitogen-Activated Protein Kinases; Nerve Growth Factor; Piperidines; Polyunsaturated Alkamides; Prolactin; Proto-Oncogene Proteins c-raf; Pyrazoles; Receptors, Prolactin; Rimonabant; Tumor Cells, Cultured | 1999 |
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
Topics: Amyloid beta-Peptides; Arachidonic Acids; Cannabinoids; Corticotropin-Releasing Hormone; Endocannabinoids; Enzyme Inhibitors; Flavonoids; Glycerides; Humans; Mitogen-Activated Protein Kinases; Nervous System Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Oxidation-Reduction; Peptide Fragments; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug | 2002 |